In classical Hodgkin lymphoma (cHL), the survival of neoplastic cells is mediated by the activation of NF-κB, JAK/STAT and PI3K/Akt signaling pathways. The gene discussed is NFKB1; the disease is classic Hodgkin lymphoma.